Maffioli L - Search Results

1

CA 15.3 as a signal of undetectable breast cancer metastases in a follow-up period of 4 years.

Pizzichetta M, Bogni A, Seregni E, Maffioli L, de Jager E, Costa A, Bombardieri E. Pizzichetta M, et al. Among authors: maffioli l. Int J Biol Markers. 1992 Jan-Mar;7(1):59-60. doi: 10.1177/172460089200700109. Int J Biol Markers. 1992. PMID: 1583349 No abstract available.

2

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases.

Bombardieri E, Pizzichetta M, Veronesi P, Seregni E, Bogni A, Maffioli L, Jotti GS, Bassetto MA, Zurrida S, Costa A. Bombardieri E, et al. Among authors: maffioli l. Eur J Cancer. 1992;29A(1):144-6. doi: 10.1016/0959-8049(93)90595-7. Eur J Cancer. 1992. PMID: 1445733

3

Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.

Crippa F, Bombardieri E, Seregni E, Castellani MR, Gasparini M, Maffioli L, Pizzichetta M, Buraggi GL. Crippa F, et al. Among authors: maffioli l. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):52-5. J Nucl Biol Med (1991). 1992. PMID: 1450226

4

Pilot, multicenter and prospective trials with an anti-CEA antibody.

Buraggi GL, Gasparini M, Seregni E, Bombardieri E, Regalia E, Maffioli L. Buraggi GL, et al. Among authors: maffioli l. Int J Biol Markers. 1992 Jul-Sep;7(3):189-92. doi: 10.1177/172460089200700312. Int J Biol Markers. 1992. PMID: 1431344 Clinical Trial.

5

Mucinic tumor markers recognized by monoclonal antibodies.

Seregni E, Bombardieri E, Maffioli L, Buraggi GL. Seregni E, et al. Among authors: maffioli l. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4):314-20. J Nucl Med Allied Sci. 1990. PMID: 2090797 Review. No abstract available.

6

Enhancement of in vivo monoclonal antibody targeting with recombinant interferon and cytokines.

Gasparini M, Zampino MG, Maffioli L, De Braud F, Bombardieri E, Buraggi GL. Gasparini M, et al. Among authors: maffioli l. Int J Biol Markers. 1993 Jul-Sep;8(3):160-5. doi: 10.1177/172460089300800305. Int J Biol Markers. 1993. PMID: 7506284 Clinical Trial.

7

Radiopharmaceuticals for breast cancer imaging.

Maffioli L, Seregni E, Chiti A, Molteni SN, Crippa F, Botti C, Bogni A, Agresti R, Bombardieri E. Maffioli L, et al. Tumori. 1997 Mar-Apr;83(2):512-4. doi: 10.1177/030089169708300202. Tumori. 1997. PMID: 9226006 No abstract available.

8

Role of bone scan in breast cancer follow-up.

Maffioli L, Zambetti M, Castellani MR, Bombardieri E. Maffioli L, et al. Tumori. 1997 Mar-Apr;83(2):547-9. doi: 10.1177/030089169708300213. Tumori. 1997. PMID: 9226017 No abstract available.

9

Breast cancer seeking agents: basic approach.

Maffioli L, Seregni E, Nerini Molteni S, Massaron S, Crippa F, Bombardieri E. Maffioli L, et al. Q J Nucl Med. 1997 Sep;41(3):211-24. Q J Nucl Med. 1997. PMID: 9274129 Review.

10

[Nuclear medicine approach for the detection and characterization of liver metastasis].

Maffioli L, Spinelli A, Bombardieri E. Maffioli L, et al. Ann Ital Chir. 1996 Nov-Dec;67(6):751-9. Ann Ital Chir. 1996. PMID: 9214267 Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters